Vanflyta-Quizartinib
Vanflyta is an oral medicine used with chemotherapy for adults newly diagnosed with FLT3‑ITD positive acute myeloid leukemia. It continues working as a maintenance therapy to help keep the cancer in check.
Xdemvy-Lotilaner
Xdemvy is an eye drop treatment that targets and kills Demodex mites to treat blepharitis (eyelid inflammation). Apply twice daily for six weeks to clear up symptoms.
Zelsuvmi-Berdazimer
Zelsuvmi is a topical gel applied to molluscum contagiosum skin lesions in patients aged one year and older. The gel releases nitric oxide to clear lesions and is the only at-home prescription treatment for this viral infection.
Zurzuvae-Zuranolone
Zurzuvae is a 14-day oral pill for adults with postpartum depression, offering rapid improvement in depressive symptoms. It helps new mothers regain mood balance after childbirth.
Exblifep-Cefepime And Enmetazobactam
Exblifep is an antibiotic drug used in adults to treat complicated urinary tract infections, such as kidney infections, hospital-acquired pneumonia, including ventilator-associated pneumonia, and bacteraemia when associated or suspected to be associated with these infections.
Rezdiffra-Resmetirom
Rezdiffra is a prescription medication indicated for the treatment of non-cirrhotic non-alcoholic steatohepatitis (NASH) in individuals with mild to severe hepatic fibrosis. It is used to promote improved liver health in conjunction with a balanced diet and consistent exercise.
Tryvio-Aprocitentan
Tryvio is an oral tablet that lowers blood pressure in adults whose hypertension isn’t managed well despite using multiple medications. It blocks endothelin receptors to relax blood vessels, reducing risks of stroke and heart attack.
Duvyzat-Givinostat
Duvyzat is an oral histone deacetylase inhibitor prescribed for Duchenne muscular dystrophy in patients aged six and older. It slows muscle degeneration, reduces inflammation, and supports muscle strength by modulating gene regulation processes.
Vafseo-Vadadustat
Vafseo is an oral tablet that treats anemia in adults with chronic kidney disease on dialysis by boosting natural erythropoietin production through HIF‑prolyl hydroxylase inhibition. It minimizes the need for blood transfusions while carrying a caution for cardiovascular and clotting risks .
Wainua-Eplontersen
Wainua is a subcutaneous injection designed for adults managing nerve damage caused by hereditary transthyretin-mediated amyloidosis (ATTRv‑PN). It works via an antisense therapy that reduces the abnormal protein buildup damaging the nerves.
